Establishment of stromal cell line from an MDS RA patient which induced an apoptopic change in hematopoietic and leukemic cells in vitro

Experimental Hematology

Volumn 28, Issue 2, 2000, Pages 148-155

  Aizawa, Shin ^a   Hiramoto, Masaki ^a   Hoshi, Hajime ^a   Toyama, Keisule ^b   Shima, Daisuke ^c   Handa, Hiroshi ^c  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c Tokyo Metropolitan University   (Japan)

Author keywords

Apoptosis; Bone marrow stromal cell; CD34 positive cell; Leukemia; Myelodysplastic syndrome; Recombinant SV40 adenovirus vector

Indexed keywords

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SIMIAN VIRUS 40; STROMA CELL;

ANEMIA, REFRACTORY; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; STROMAL CELLS;

EID: 0033964098     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00142-3     Document Type: Article

References (31)

1. Koeffler H.P. Myelodysplastic syndrome (preleukemia). Semin Haematol. 23:1986;284.
2. Janssen W.G., Buschle M., Layton M., Drexler H.G., Lyons J., van den Berge H., Heipel H., Kubanek B., Klerhauer E., Mufti G.J., Bartran R. Clonal analysis of myelodysplastic syndromes. evidence of a multipotent stem cell origin Blood. 73:1989;248.
3. Greenberg P.L. The smoldering myeloid leukemia states. clinical and biological features Blood. 61:1983;1035.
4. Verma D.S., Spitzer G., Dicke K.A., McCredie K.B. In vitro agar culture patterns in preleukemia and their clinical significance. Leuk Res. 3:1979;41.
5. Chui D.H.K., Clarke B.J. Abnormal erythroid progenitor cells in human preleukemia. Blood. 60:1982;362.
6. Gold E.J., Conjalka M., Pelus L.M., Jhanwar S.C., Broxmeyer H., Middleton A.B., Clarkson B.D., Moore M.A.S. Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes. insights to pathophysiology and prognosis J Clin Oncol. 1:1983;627.
7. Ruutu T., Partanen S., Lintula R., Teerenhovi L., Knuutila S. Erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Scand J Haematol. 32:1984;395.
8. Swanson G., Picozzi V., Morgan R., Hecht F., Greenberg P.L. Responses of hemopoietic precursors to 13-cis retinoic acid and 1,25 dihydroxyvitanim D3 in the myelodysplastic syndromes. Blood. 67:1986;1154.
9. Raza A., Yousuf N., Bokhari S.A.J., Sheikh Y., Akhtar S., Chughtai S., Umerani A., Mehdi S.A., Miller M.A., Masterson M., Lampkin B. In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies. Anticancer Res. 12:1992;403.
10. Raza A., Mundle S., Iftikhar A., Gregory S., Marcus B., Khan Z., Alvi S., Shetty V., Dameron S., Wright V., Adler S., Loew J.M., Shott S., Ali S.N., Preisler H. Simultanous assessment of cell kinetics and programmed cell death in bone marrowbiopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol. 48:1995;143.
11. Wetzler M., Kurzrock R., Estrov Z., Estey E., Talpaz M. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Leuk Res. 19:1995;23.
12. Hirayama Y., Kohgo Y., Matsunaga T., Ohi S., Sakamaki S., Niitsu Y. Cytokine mRNA expression of bone marrow stromal cells from patients with aplastic anaemia and myelodysplastic syndrome. Br J Haematol. 85:1993;676.
13. Coutinho L.H., Geary C.G., Chabg J., Harrison C., Testa N.G. Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndrome (MDS). Br J Haematol. 75:1990;16.
14. Aizawa S., Nakano M., Iwase O., Yaguchi M., Hiramoto M., Hoshi H., Nabeshima R., Shima D., Handa H., Toyama K. Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro. Leuk Res. 23:1999;239.
15. Aizawa S., Yaguchi M., Nakano M., Inokuchi S., Handa H., Toyama K. Establishment of a variety of human marrow stromal cell lines by the recombinant SV40-adenovirus vector. J Cell Physiol. 148:1991;245.
16. Aizawa S., Yaguchi M., Nakano M., Toyama K., Inokuchi S., Imai T., Yasuda M., Nabeshima R., Handa H. Hemopoietic supportive function of human bone marrow stromal cell lines established by a recombinant SV40-adenovirus vector. Exp Hematol. 22:1994;482.
17. Hiramoto M., Aizawa S., Iwase O., Nakano M., Toyama K., Hoque M., Nabeshima R., Kaidow A., Imai T., Hoshi H., Handa H. Stimulatory effects of substance P on CD34 positive cell proliferation and differentiation in vitro are mediated by the modulation of stromal cell function. Int J Mol Med. 1:1998;347.
18. Van Doren K., Gluzman Y. Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants. Mol Cell Biol. 4:1984;1653.
19. Zhang C., Ao Z., Seth A., Schlossman S.F. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol. 157:1996;3980.
20. Maniatis T, Fritsch EF, Sambrook J (1989) Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
21. Nabeshima R., Aizawa S., Nakano M., Toyama K., Sugimoto K., Kaidow A., Imai T., Handa H. Effects of vesnarinone on the bone marrow stroma cell-dependent proliferation and differentiation of HL60 cells in vitro. Exp Hematol. 25:1997;509.
22. Aizawa S., Nakano M., Yaguchi M., Kuriyama Y., Iwase O., Toyama K., Tanaka K., Hoshi H., Sugimoto K., Kaido A., Imai T., Nabeshima R., Handa H. Possible involvement of bone marrow stromal cells in agranulocytosis caused by vesnarinone treatment. Acta Haematol. 98:1997;140.
23. Dexter T.M., Allen T.D., Lajtha L.G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol. 91:1977;335.
24. Mori K.J., Fujitake H., Okubo H., Dexter T.M., Ito Y. Quantitative development of adherent cell colonies in bone marrow cell culture in vitro. Exp Hematol. 7:1979;171.
25. Liesveld J.L., Harbol A.W., Abboud C.N. Stem cell factor and stromal cell co-culture prevent apoptosis in a subculture of the megakaryoblastic cell line, UT-7. Leuk Res. 20:1996;591.
26. Murohashi I., Yoshida K., Handa A., Murayoshi M., Yoshida S., Jinnai I., Bessho M., Hirashima K. Differential regulation by hematopoietic growth factors of apoptosis and mitosis in acute myeloblastic leukemia cells. Exp Hematol. 25:1997;1042.
27. Bendall L.J., Daniel A., Kortlepel K., Gottlieb D.J. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. Exp Hematol. 22:1994;1252.
28. Bendall L.J., Makrynikola V., Hutchinson A., Bianchi A.C., Bradstock K.F., Gottlieb D.J. Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals. Leukemia. 12:1998;1375.
29. Campana D., Coustan-Smith E., Manabe A., Kumagai M., Murti K.G., Silvennoinen O., Nishigaki H., Kitanaka A., Ito C. Human B-cell progenitors and bone marrow microenvironment. Hum Cell. 9:1996;317.
30. Manabe A., Murti K.G., Coustan-Smith E., Kumagai M., Behn F.G., Raimondi S.C., Camana D. Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood. 83:1994;758.
31. Selleri C., Maciejewski J.P., Sato T., Young N.S. Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow culture mediates potent hematopoietic inhibition. Blood. 87:1996;4149.